Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease

Science Advances(2020)10.1126/sciadv.aaz2387Source: DataRank Database

Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease is a research paper published in Science Advances (2020). On theSindex it has a DataRank of 0. It has been cited 374 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access374 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (23 grants)Impact (FWCI 23.44)OA: goldTopics (22)Linked Datasets (25)DataCite Reuse (25)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Emelie Andersson,Shorena Janelidze ORCID,Rik Ossenkoppele ORCID,Philip S. Insel ORCID,Olof Strandberg

Live enrichment

PubMed:32426454 PMC:PMC7159908 OpenAlex:https://openalex.org/W3016877536

NIA NIH HHS

Grant: P30 AG062422

NINDS NIH HHS

Grant: U54 NS092089

NIA NIH HHS

Grant: U01 AG045390

NIA NIH HHS

Grant: U19 AG063911

NIA NIH HHS

Grant: P01 AG019724

NIA NIH HHS

Grant: R01 AG038791

NIA NIH HHS

Grant: K24 AG045333

Medical Research Council

Grant: UKDRI-1003

Parkinson Research Foundation

Torsten Söderberg Foundation

Swedish Medical Association

European Research Council

Marianne and Marcus Wallenberg Foundation

Strategic Research Area MultiPark

Swedish Alzheimer Foundation

the Knut and Alice Wallenberg Foundation

Skåne University Hospital Foundation

Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse

Swedish Research Council Formas

Medical Faculty at Lund University

Parkinson foundation of Sweden

Region Skåne

Swedish Brain Foundation

FWCI

23.44

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://advances.sciencemag.org/content/advances/6/16/eaaz2387.full.pdf

publisherhttps://advances.sciencemag.org/content/advances/6/16/eaaz2387.full.pdf

publisherhttps://www.science.org/doi/pdf/10.1126/sciadv.aaz2387

journalhttps://doi.org/10.1126/sciadv.aaz2387

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32426454

Fields of Study

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroscience and Neuropharmacology Research

MeSH Terms

Alzheimer DiseaseAnimalsPhosphorylationBiomarkersAmyloid beta-Peptidestau ProteinsPositron-Emission TomographyMice

Keywords

Deposition (geology)DiseasePhosphorylationAlzheimer's diseaseNeuroscienceCancer researchCell biologyChemistryMedicineInternal medicineBiology

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain

10.6084/m9.figshare.12886049.v1figshare

Additional file 1 of Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain

10.6084/m9.figshare.12886049figshare

Additional file 1 of Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer’s disease: findings from the Colombia-Boston (COLBOS) biomarker study

10.6084/m9.figshare.13585296.v1figshare

Additional file 1 of Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer’s disease: findings from the Colombia-Boston (COLBOS) biomarker study

10.6084/m9.figshare.13585296figshare

Additional file 2 of Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer’s disease: findings from the Colombia-Boston (COLBOS) biomarker study

10.6084/m9.figshare.13585299.v1figshare

Additional file 2 of Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer’s disease: findings from the Colombia-Boston (COLBOS) biomarker study

10.6084/m9.figshare.13585299figshare

Additional file 3 of Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer’s disease: findings from the Colombia-Boston (COLBOS) biomarker study

10.6084/m9.figshare.13585302.v1figshare

Additional file 3 of Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer’s disease: findings from the Colombia-Boston (COLBOS) biomarker study

10.6084/m9.figshare.13585302figshare

Additional file 4 of Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer’s disease: findings from the Colombia-Boston (COLBOS) biomarker study

10.6084/m9.figshare.13585305.v1figshare

Additional file 4 of Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer’s disease: findings from the Colombia-Boston (COLBOS) biomarker study

10.6084/m9.figshare.13585305figshare

Additional file 5 of Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer’s disease: findings from the Colombia-Boston (COLBOS) biomarker study

10.6084/m9.figshare.13585308.v1figshare

Additional file 5 of Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer’s disease: findings from the Colombia-Boston (COLBOS) biomarker study

10.6084/m9.figshare.13585308figshare

Additional file 1 of Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET

10.6084/m9.figshare.14538932.v1figshare

Additional file 1 of Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET

10.6084/m9.figshare.14538932figshare

Additional file 1 of Age, vascular disease, and Alzheimer’s disease pathologies in amyloid negative elderly adults

10.6084/m9.figshare.16821790.v1figshare

Additional file 1 of Age, vascular disease, and Alzheimer’s disease pathologies in amyloid negative elderly adults

10.6084/m9.figshare.16821790figshare

Additional file 1 of The relationship of insulin resistance and diabetes to tau PET SUVR in middle-aged to older adults

10.6084/m9.figshare.22618903.v1figshare

Additional file 1 of The relationship of insulin resistance and diabetes to tau PET SUVR in middle-aged to older adults